Not 3 weeks af­ter tak­ing Hu­ma­cyte pub­lic, Ra­jiv Shuk­la launch­es an­oth­er blank check com­pa­ny

One of biotech’s ear­li­est SPAC in­vestors is back with an­oth­er blank check com­pa­ny, less than a month af­ter his last ef­fort an­nounced its in­tent to merge.

Ra­jiv Shuk­la is in­tend­ing to take a third lucky win­ner pub­lic with Al­pha Health­care Ac­qui­si­tion III, fil­ing to go pub­lic Thurs­day with a $150 mil­lion raise pen­ciled in. The move comes just a cou­ple of weeks af­ter Shuk­la’s sec­ond SPAC said it would jump to Nas­daq in tan­dem with Lau­ra Nikla­son’s Hu­ma­cyte in a $255 mil­lion new in­vest­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.